SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-23-088978 from YIELD10 BIOSCIENCE, INC. (YTEN) (CIK 0001121702)

YIELD10 BIOSCIENCE, INC. (YTEN) (CIK 0001121702)
Date: Aug. 8, 2023 · CIK: 0001121702 · Accession: 0001104659-23-088978

AI Filing Summary & Sentiment

Date
August 8, 2023
Author
Co-President
Form
CORRESP
Company
YIELD10 BIOSCIENCE, INC. (YTEN) (CIK 0001121702)

Letter

MAXIM GROUP LLC

300 Park Avenue, 16th Floor

New York, New York 10022

August 8, 2023

VIA EDGAR CORRESPONDENCE

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Attn.: Jessica Ansart

Re: Yield10 Bioscience, Inc. (the “Company)

Registration Statement on Form S-1, as amended (the “Registration Statement”)

File No. 333- 273240

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), we, as lead manager, hereby request that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement to become effective at 5:00 p.m., Eastern time, on Wednesday, August 9, 2023, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated August 2, 2023 to agents, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned, as placement agent, has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very truly yours,
MAXIM GROUP LLC

Show Raw Text
CORRESP
1
filename1.htm

MAXIM GROUP LLC

300 Park Avenue, 16th Floor

New York, New York 10022

August 8, 2023

VIA EDGAR CORRESPONDENCE

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    100 F. Street, N.E.

    Washington, D.C. 20549

    Attn.: Jessica Ansart

 Re: Yield10 Bioscience, Inc. (the “Company)

Registration Statement on Form S-1, as amended (the “Registration Statement”)

File No. 333- 273240

Ladies and Gentlemen:

Pursuant to Rule 461 of the
General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), we, as lead manager, hereby request
that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced
Registration Statement to become effective at 5:00 p.m., Eastern time, on Wednesday, August 9, 2023, or as soon thereafter as practicable.

Pursuant to Rule 460 under
the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated August 2, 2023 to agents, dealers,
institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned, as placement
agent, has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

    Very truly yours,

    MAXIM GROUP LLC

    By:
    /s/ Clifford A. Teller

    Name:
    Clifford A. Teller

    Title:
    Co-President